Abstract
Congenital heart defect (CHD) is the most common form of birth deformity and is responsible for substantial morbidity and mortality in humans. Increasing evidence has convincingly demonstrated that genetic defects play a pivotal role in the pathogenesis of CHD. However, CHD is a genetically heterogeneous disorder and the genetic basis underpinning CHD in the vast majority of cases remains elusive. This study was sought to identify the pathogenic mutation in the ISL1 gene contributing to CHD. A cohort of 210 unrelated patients with CHD and a total of 256 unrelated healthy individuals used as controls were registered. The coding exons and splicing boundaries of ISL1 were sequenced in all study subjects. The functional effect of an identified ISL1 mutation was evaluated using a dual-luciferase reporter assay system. A novel heterozygous ISL1 mutation, c.409G > T or p.E137X, was identified in an index patient with congenital patent ductus arteriosus and ventricular septal defect. Analysis of the proband’s pedigree revealed that the mutation co-segregated with CHD, which was transmitted in the family in an autosomal dominant pattern with complete penetrance. The nonsense mutation was absent in 512 control chromosomes. Functional analysis unveiled that the mutant ISL1 protein failed to transactivate the promoter of MEF2C, alone or in synergy with TBX20. This study firstly implicates ISL1 loss-of-function mutation with CHD in humans, which provides novel insight into the molecular mechanism of CHD, implying potential implications for genetic counseling and individually tailored treatment of CHD patients.
Similar content being viewed by others
References
Zaidi S, Brueckner M (2017) Genetics and genomics of congenital heart disease. Circ Res 120:923–940
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O’Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2018) Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation 137:e67–e492
Ernst MM, Marino BS, Cassedy A, Piazza-Waggoner C, Franklin RC, Brown K, Wray J (2018) Biopsychosocial predictors of quality of life outcomes in pediatric congenital heart disease. Pediatr Cardiol 39:79–88
Banks L, Rosenthal S, Manlhiot C, Fan CS, McKillop A, Longmuir PE, McCrindle BW (2017) Exercise capacity and self-efficacy are associated with moderate-to-vigorous intensity physical activity in children with congenital heart disease. Pediatr Cardiol 38:1206–1214
Morton PD, Ishibashi N, Jonas RA (2017) Neurodevelopmental abnormalities and congenital heart disease: insights into altered brain maturation. Circ Res 120:960–977
Peyvandi S, Chau V, Guo T, Xu D, Glass HC, Synnes A, Poskitt K, Barkovich AJ, Miller SP, McQuillen PS (2018) Neonatal brain injury and timing of neurodevelopmental assessment in patients with congenital heart disease. J Am Coll Cardiol 71:1986–1996
Zorzanelli L, Maeda N, Clavé M, Thomaz A, Galas F, Rabinovitch M, Lopes A (2017) Relation of cytokine profile to clinical and hemodynamic features in young patients with congenital heart disease and pulmonary hypertension. Am J Cardiol 119:119–125
van der Feen DE, Bartelds B, de Boer RA, Berger RM (2017) Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease. Eur Heart J 38:2034–2041
Schwartz SS, Madsen N, Laursen HB, Hirsch R, Olsen MS (2018) Incidence and mortality of adults with pulmonary hypertension and congenital heart disease. Am J Cardiol 121:1610–1616
Muneuchi J, Ochiai Y, Masaki N, Okada S, Iida C, Sugitani Y, Ando Y, Watanabe M (2018) Pulmonary arterial compliance is a useful predictor of pulmonary vascular disease in congenital heart disease. Heart Vessels. https://doi.org/10.1007/s00380-018-1263-9
Lanz J, Brophy JM, Therrien J, Kaouache M, Guo L, Marelli AJ (2015) Stroke in adults with congenital heart disease: incidence, cumulative risk, and predictors. Circulation 132:2385–2394
Masuda K, Ishizu T, Niwa K, Takechi F, Tateno S, Horigome H, Aonuma K (2017) Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias. Int J Cardiol 234:69–75
Giang KW, Mandalenakis Z, Dellborg M, Lappas G, Eriksson P, Hansson PO, Rosengren A (2018) Long-term risk of hemorrhagic stroke in young patients with congenital heart disease. Stroke 49:1155–1162
Forte A, Grossi M, Bancone C, Cipollaro M, De Feo M, Hellstrand P, Persson L, Nilsson BO, Della Corte A (2018) Polyamine concentration is increased in thoracic ascending aorta of patients with bicuspid aortic valve. Heart Vessels 33:327–339
Diller GP, Baumgartner H (2017) Endocarditis in adults with congenital heart disease: new answers-new questions. Eur Heart J 38:2057–2059
Mylotte D, Rushani D, Therrien J, Guo L, Liu A, Guo K, Martucci G, Mackie AS, Kaufman JS, Marelli A (2017) Incidence, predictors, and mortality of infective endocarditis in adults with congenital heart disease without prosthetic valves. Am J Cardiol 120:2278–2283
Kuijpers JM, Koolbergen DR, Groenink M, Peels KC, Reichert CL, Post MC, Bosker HA, Wajon EM, Zwinderman AH, Mulder BJ, Bouma BJ (2017) Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J 38:2048–2056
Tutarel O, Alonso-Gonzalez R, Montanaro C, Schiff R, Uribarri A, Kempny A, Grübler MR, Uebing A, Swan L, Diller GP, Dimopoulos K, Gatzoulis MA (2018) Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart 104:161–165
Ciepłucha A, Trojnarska O, Kociemba A, Łanocha M, Barczynski M, Rozmiarek S, Kramer L, Pyda M (2018) Clinical aspects of myocardial fibrosis in adults with Ebstein’s anomaly. Heart Vessels 33:1076–1085
Lluri G, Renella P, Finn JP, Vorobiof G, Aboulhosn J, Deb A (2017) Prognostic significance of left ventricular fibrosis in patients with congenital bicuspid aortic valve. Am J Cardiol 120:1176–1179
Miyazaki A, Sakaguchi H, Noritake K, Hayama Y, Negishi J, Kagisaki K, Yasuda K, Ichikawa H, Ohuchi H (2017) Interventricular dyssynchrony in a patient with a biventricular physiology and a systemic right ventricle. Heart Vessels 32:234–239
Shiina Y, Inai K, Takahashi T, Taniguchi K, Watanabe E, Fukushima K, Niwa K, Nagao M (2018) Inter- and intra-ventricular dyssynchrony in the systemic right ventricle is a surrogate marker of major cardiac events in mildly symptomatic patients. Heart Vessels 33:1086–1093
Hinton RB, Ware SM (2017) Heart failure in pediatric patients with congenital heart disease. Circ Res 120:978–994
Isogai T, Matsui H, Tanaka H, Kohyama A, Fushimi K, Yasunaga H (2018) Clinical features and peripartum outcomes in pregnant women with cardiac disease: a nationwide retrospective cohort study in Japan. Heart Vessels 33:918–930
Shaddy RE, George AT, Jaecklin T, Lochlainn EN, Thakur L, Agrawal R, Solar-Yohay S, Chen F, Rossano JW, Severin T, Burch M (2018) Systematic literature review on the incidence and prevalence of heart failure in children and adolescents. Pediatr Cardiol 39:415–436
Labombarda F, Hamilton R, Shohoudi A, Aboulhosn J, Broberg CS, Chaix MA, Cohen S, Cook S, Dore A, Fernandes SM, Fournier A, Kay J, Macle L, Mondésert B, Mongeon FP, Opotowsky AR, Proietti A, Rivard L, Ting J, Thibault B, Zaidi A, Khairy P, AARCC (2017) Increasing prevalence of atrial fibrillation and permanent atrial arrhythmias in congenital heart disease. J Am Coll Cardiol 70:857–865
McLeod CJ (2017) Acute arrhythmias in adults with congenital heart disease. Heart 103:1380–1388
Holst KA, Said SM, Nelson TJ, Cannon BC, Dearani JA (2017) Current interventional and surgical management of congenital heart disease: specific focus on valvular disease and cardiac arrhythmias. Circ Res 120:1027–1044
Hernández-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K; ESC Scientific Document Group (2018) Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace https://doi.org/10.1093/europace/eux380
Koyak Z, de Groot JR, Bouma BJ, Zwinderman AH, Silversides CK, Oechslin EN, Budts W, Van Gelder IC, Mulder BJ, Harris L (2017) Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen? Europace 19:401–406
Moore B, Yu C, Kotchetkova I, Cordina R, Celermajer DS (2018) Incidence and clinical characteristics of sudden cardiac death in adult congenital heart disease. Int J Cardiol 254:101–106
Lynge TH, Jeppesen AG, Winkel BG, Glinge C, Schmidt MR, Søndergaard L, Risgaard B, Tfelt-Hansen J (2018) Nationwide study of sudden cardiac death in people with congenital heart defects aged 0 to 35 years. Circ Arrhythm Electrophysiol 11:e005757
Izumi G, Senzaki H, Takeda A, Yamazawa H, Takei K, Furukawa T, Inai K, Shinohara T, Nakanishi T (2017) Significance of right atrial tension for the development of complications in patients after atriopulmonary connection Fontan procedure: potential indicator for Fontan conversion. Heart Vessels 32:850–855
Saito C, Fukushima N, Fukushima K, Matsumura G, Ashihara K, Hagiwara N (2017) Factors associated with aortic root dilatation after surgically repaired ventricular septal defect. Echocardiography 34:1203–1209
Shinkawa T, Chipman C, Holloway J, Tang X, Gossett JM, Imamura M (2017) Single center experience of aortic bypass graft for aortic arch obstruction in children. Heart Vessels 32:76–82
Henmi R, Ejima K, Yagishita D, Iwanami Y, Nishimura T, Takeuchi D, Toyohara K, Shoda M, Hagiwara N (2017) Long-term efficacy of implantable cardioverter defibrillator in repaired tetralogy of Fallot—role of anti-tachycardia pacing. Circ J 81:165–171
Kim J, Kuwata S, Kurishima C, Iwamoto Y, Ishido H, Masutani S, Senzaki H (2018) Importance of dynamic central venous pressure in Fontan circulation. Heart Vessels 33:664–670
Takahashi T, Shiina Y, Nagao M, Inai K (2018) Stroke volume ratio derived from magnetic resonance imaging as an indicator of interventricular dyssynchrony predicts future cardiac event in patients with biventricular Fontan circulation. Heart Vessels. https://doi.org/10.1007/s00380-018-1217-2
Hasegawa T, Masuda M, Okumura M, Arai H, Kobayashi J, Saiki Y, Tanemoto K, Nishida H, Motomura N (2017) Trends and outcomes in neonatal cardiac surgery for congenital heart disease in Japan from 1996 to 2010. Eur J Cardiothorac Surg 51:301–307
Bouma BJ, Mulder BJ (2017) Changing landscape of congenital heart disease. Circ Res 120:908–922
Mandalenakis Z, Rosengren A, Skoglund K, Lappas G, Eriksson P, Dellborg M (2017) Survivorship in children and young adults with congenital heart disease in Sweden. JAMA Intern Med 177:224–230
Hayabuchi Y, Ono A, Homma Y, Kagami S (2018) Pulmonary annular motion velocity reflects right ventricular outflow tract function in children with surgically repaired congenital heart disease. Heart Vessels 33:316–326
Blue GM, Kirk EP, Giannoulatou E, Sholler GF, Dunwoodie SL, Harvey RP, Winlaw DS (2017) Advances in the genetics of congenital heart disease: a clinician’s guide. J Am Coll Cardiol 69:859–870
Akhirome E, Walton NA, Nogee JM, Jay PY (2017) The complex genetic basis of congenital heart defects. Circ J 81:629–634
Li YJ, Yang YQ (2017) An update on the molecular diagnosis of congenital heart disease: focus on loss-of-function mutations. Expert Rev Mol Diagn 17:393–401
Fahed AC, Gelb BD, Seidman JG, Seidman CE (2013) Genetics of congenital heart disease: the glass half empty. Circ Res 112:707–720
Wang X, Chang WL, Chen CA, Rosenfeld JA, Al Shamsi A, Al-Gazali L, McGuire M, Mew NA, Arnold GL, Qu C, Ding Y, Muzny DM, Gibbs RA, Eng CM, Walkiewicz M, Xia F, Plon SE, Lupski JR, Schaaf CP, Yang Y (2017) Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations. Nat Genet 49:613–617
Jin SC, Homsy J, Zaidi S, Lu Q, Morton S, DePalma SR, Zeng X, Qi H, Chang W, Sierant MC, Hung WC, Haider S, Zhang J, Knight J, Bjornson RD, Castaldi C, Tikhonoa IR, Bilguvar K, Mane SM, Sanders SJ, Mital S, Russell MW, Gaynor JW, Deanfield J, Giardini A, Porter GA Jr, Srivastava D, Lo CW, Shen Y, Watkins WS, Yandell M, Yost HJ, Tristani-Firouzi M, Newburger JW, Roberts AE, Kim R, Zhao H, Kaltman JR, Goldmuntz E, Chung WK, Seidman JG, Gelb BD, Seidman CE, Lifton RP, Brueckner M (2017) Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet 49:1593–1601
Liu X, Yagi H, Saeed S, Bais AS, Gabriel GC, Chen Z, Peterson KA, Li Y, Schwartz MC, Reynolds WT, Saydmohammed M, Gibbs B, Wu Y, Devine W, Chatterjee B, Klena NT, Kostka D, de Mesy Bentley KL, Ganapathiraju MK, Dexheimer P, Leatherbury L, Khalifa O, Bhagat A, Zahid M, Pu W, Watkins S, Grossfeld P, Murray SA, Porter GA Jr, Tsang M, Martin LJ, Benson DW, Aronow BJ, Lo CW (2017) The complex genetics of hypoplastic left heart syndrome. Nat Genet 49:1152–1159
Tan TY, Gonzaga-Jauregui C, Bhoj EJ, Strauss KA, Brigatti K, Puffenberger E, Li D, Xie L, Das N, Skubas I, Deckelbaum RA, Hughes V, Brydges S, Hatsell S, Siao CJ, Dominguez MG, Economides A, Overton JD, Mayne V, Simm PJ, Jones BO, Eggers S, Le Guyader G, Pelluard F, Haack TB, Sturm M, Riess A, Waldmueller S, Hofbeck M, Steindl K, Joset P, Rauch A, Hakonarson H, Baker NL, Farlie PG (2017) Monoallelic BMP2 variants predicted to result in haploinsufficiency cause craniofacial, skeletal, and cardiac features overlapping those of 20p12 deletions. Am J Hum Genet 101:985–994
Hempel M, Casar Tena T, Diehl T, Burczyk MS, Strom TM, Kubisch C, Philipp M, Lessel D (2017) Compound heterozygous GATA5 mutations in a girl with hydrops fetalis, congenital heart defects and genital anomalies. Hum Genet 136:339–346
Wang J, Hu XQ, Guo YH, Gu JY, Xu JH, Li YJ, Li N, Yang XX, Yang YQ (2017) HAND1 loss-of-function mutation causes tetralogy of Fallot. Pediatr Cardiol 38:547–557
Li L, Wang J, Liu XY, Liu H, Shi HY, Yang XX, Li N, Li YJ, Huang RT, Xue S, Qiu XB, Yang YQ (2017) HAND1 loss-of-function mutation contributes to congenital double outlet right ventricle. Int J Mol Med 39:711–718
Xu YJ, Qiu XB, Yuan F, Shi HY, Xu L, Hou XM, Qu XK, Liu X, Huang RT, Xue S, Yang YQ, Li RG (2017) Prevalence and spectrum of NKX2.5 mutations in patients with congenital atrial septal defect and atrioventricular block. Mol Med Rep 15:2247–2254
Chen HX, Zhang X, Hou HT, Wang J, Yang Q, Wang XL, He GW (2017) Identification of a novel and functional mutation in the TBX5 gene in a patient by screening from 354 patients with isolated ventricular septal defect. Eur J Med Gene 60:385–390
Ramond F, Duband S, Croisille P, Cavé H, Teyssier G, Adouard V, Touraine R (2017) Expanding the cardiac spectrum of Noonan syndrome with RIT1 variant: left main coronary artery atresia causing sudden death. Eur J Med Genet 60:299–302
Guo C, Wang Q, Wang Y, Yang L, Luo H, Cao XF, An L, Qiu Y, Du M, Ma X, Li H, Lu C (2017) Exome sequencing reveals novel IRXI mutation in congenital heart disease. Mol Med Rep 15:3193–3197
Huang RT, Wang J, Xue S, Qiu XB, Shi HY, Li RG, Qu XK, Yang XX, Liu H, Li N, Li YJ, Xu YJ, Yang YQ (2017) TBX20 loss-of-function mutation responsible for familial tetralogy of Fallot or sporadic persistent truncus arteriosus. Int J Med Sci 14:323–332
Qiao XH, Wang F, Zhang XL, Huang RT, Xue S, Wang J, Qiu XB, Liu XY, Yang YQ (2017) MEF2C loss-of-function mutation contributes to congenital heart defects. Int J Med Sci 14:1143–1153
Zhang M, Li FX, Liu XY, Huang RT, Xue S, Yang XX, Li YJ, Liu H, Shi HY, Pan X, Qiu XB, Yang YQ (2017) MESP1 loss–of–function mutation contributes to double outlet right ventricle. Mol Med Rep 16:2747–2754
Vaidya A, Flores SK, Cheng ZM, Nicolas M, Deng Y, Opotowsky AR, Lourenço DM Jr, Barletta JA, Rana HQ, Pereira MA, Toledo RA, Dahia PLM (2018) EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease. N Engl J Med 378:1259–1261
Bashamboo A, Eozenou C, Jorgensen A, Bignon-Topalovic J, Siffroi JP, Hyon C, Tar A, Nagy P, Sólyom J, Halász Z, Paye-Jaouen A, Lambert S, Rodriguez-Buritica D, Bertalan R, Martinerie L, Rajpert-De Meyts E, Achermann JC, McElreavey K (2018) Loss of function of the nuclear receptor NR2F2, encoding COUP-TF2, causes testis development and cardiac defects in 46, XX children. Am J Hum Genet 102:487–493
Qiao XH, Wang Q, Wang J, Liu XY, Xu YJ, Huang RT, Xue S, Li YJ, Zhang M, Qu XK, Li RG, Qiu XB, Yang YQ (2018) A novel NR2F2 loss-of-function mutation predisposes to congenital heart defect. Eur J Med Genet 61:197–203
Li RG, Xu YJ, Wang J, Liu XY, Yuan F, Huang RT, Xue S, Li L, Liu H, Li YJ, Qu XK, Shi HY, Zhang M, Qiu XB, Yang YQ (2018) GATA4 loss-of-function mutation and the congenitally bicuspid aortic valve. Am J Cardiol 121:469–474
Lu CX, Wang W, Wang Q, Liu XY, Yang YQ (2018) A novel MEF2C loss-of-function mutation associated with congenital double outlet right ventricle. Pediatr Cardiol 39:794–804
Yokoyama R, Kinoshita K, Hata Y, Abe M, Matsuoka K, Hirono K, Kano M, Nakazawa M, Ichida F, Nishida N, Tabata T (2018) A mutant HCN4 channel in a family with bradycardia, left bundle branch block, and left ventricular noncompaction. Heart Vessels 33:802–819
Li X, Shi L, Xu M, Zheng X, Yu Y, Jin J (2018) RCAN1 mutation and functional characterization in children with sporadic congenital heart disease. Pediatr Cardiol 39:226–235
Nijak A, Alaerts M, Kuiperi C, Corveleyn A, Suys B, Paelinck B, Saenen J, Van Craenenbroeck E, Van Laer L, Loeys B, Verstraeten A (2018) Left ventricular non-compaction with Ebstein anomaly attributed to a TPM1 mutation. Eur J Med Genet 61:8–10
Zhang M, Li FX, Liu XY, Hou JY, Ni SH, Wang J, Zhao CM, Zhang W, Kong Y, Huang RT, Xue S, Yang YQ (2018) TBX1 loss-of-function mutation contributes to congenital conotruncal defects. Exp Ther Med 15:447–453
Jaouadi A, Tabebi M, Abdelhedi F, Abid D, Kamoun F, Chabchoub I, Maatoug S, Doukali H, Belghuith N, Ksentini MA, Keskes LA, Triki C, Hachicha M, Kamoun S, Kamoun H (2018) A novel TBX1 missense mutation in patients with syndromic congenital heart defects. Biochem Biophys Res Commun 499:563–569
Pu T, Liu Y, Xu R, Li F, Chen S, Sun K (2018) Identification of ZFPM2 mutations in sporadic conotruncal heart defect patients. Mol Genet Genomics 293:217–223
Xu YJ, Di RM, Qiao Q, Li XM, Huang RT, Xue S, Liu XY, Wang J, Yang YQ (2018) GATA6 loss-of-function mutation contributes to congenital bicuspid aortic valve. Gene 663:115–120
Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, Chien KR (2005) Postnatal isl1 + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647–653
Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR (2006) Multipotent embryonic isl1 + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151–1165
Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, Roberts DJ, Huang PL, Domian IJ, Chien KR (2009) Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460:113–117
Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S (2003) Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5:877–889
Stevens KN, Hakonarson H, Kim CE, Doevendans PA, Koeleman BP, Mital S, Raue J, Glessner JT, Coles JG, Moreno V, Granger A, Gruber SB, Gruber PJ (2010) Common variation in ISL1 confers genetic susceptibility for human congenital heart disease. PLoS ONE 5:e10855
Luo ZL, Sun H, Yang ZQ, Ma YH, Gu Y, He YQ, Wei D, Xia LB, Yang BH, Guo T (2014) Genetic variations of ISL1 associated with human congenital heart disease in Chinese Han people. Genet Mol Res 13:1329–1338
Sun YM, Wang J, Xu YJ, Wang XH, Yuan F, Liu H, Li RG, Zhang M, Li YJ, Shi HY, Zhao L, Qiu XB, Qu XK, Yang YQ (2018) ZBTB17 loss-of-function mutation contributes to familial dilated cardiomyopathy. Heart Vessels 33:722–732
Dodou E, Verzi MP, Anderson JP, Xu SM, Black BL (2004) Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 131:3931–3942
Takeuchi JK, Mileikovskaia M, Koshiba-Takeuchi K, Heidt AB, Mori AD, Arruda EP, Gertsenstein M, Georges R, Davidson L, Mo R, Hui CC, Henkelman RM, Nemer M, Black BL, Nagy A, Bruneau BG (2005) Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Development 132:2463–2474
Friedrich FW, Dilanian G, Khattar P, Juhr D, Gueneau L, Charron P, Fressart V, Vilquin JT, Isnard R, Gouya L, Richard P, Hammoudi N, Komajda M, Bonne G, Eschenhagen T, Dubourg O, Villard E, Carrier L (2013) A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity. Eur J Heart Fail 15:267–276
Zhang H, Wang WP, Guo T, Yang JC, Chen P, Ma KT, Guan YF, Zhou CY (2009) The LIM-homeodomain protein ISL1 activates insulin gene promoter directly through synergy with BETA2. J Mol Biol 392:566–577
Yuan F, Qiu ZH, Wang XH, Sun YM, Wang J, Li RG, Liu H, Zhang M, Shi HY, Zhao L, Jiang WF, Liu X, Qiu XB, Qu XK, Yang YQ (2018) MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy. Clin Chem Lab Med 56:502–511
Gong Q, Zhou Z (2018) Nonsense-mediated mRNA decay of hERG mutations in long QT syndrome. Methods Mol Biol 1684:37–49
Inácio A, Silva AL, Pinto J, Ji X, Morgado A, Almeida F, Faustino P, Lavinha J, Liebhaber SA, Romão L (2004) Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense-mediated mRNA decay. J Biol Chem 279:32170–32180
Huang RT, Xue S, Xu YJ, Zhou M, Yang YQ (2014) Somatic GATA5 mutations in sporadic tetralogy of Fallot. Int J Mol Med 33:1227–1235
Guo DF, Li RG, Yuan F, Shi HY, Hou XM, Qu XK, Xu YJ, Zhang M, Liu X, Jiang JQ, Yang YQ, Qiu XB (2016) TBX5 loss-of-function mutation contributes to atrial fibrillation and atypical Holt-Oram syndrome. Mol Med Rep 13:4349–4356
Lu CX, Gong HR, Liu XY, Wang J, Zhao CM, Huang RT, Xue S, Yang YQ (2016) A novel HAND2 loss-of-function mutation responsible for tetralogy of Fallot. Int J Mol Med 37:445–451
Sun YM, Wang J, Qiu XB, Yuan F, Xu YJ, Li RG, Qu XK, Huang RT, Xue S, Yang YQ (2016) PITX2 loss-of-function mutation contributes to tetralogy of Fallot. Gene 577:258–264
Qiu XB, Qu XK, Li RG, Liu H, Xu YJ, Zhang M, Shi HY, Hou XM, Liu X, Yuan F, Sun YM, Wang J, Huang RT, Xue S, Yang YQ (2017) CASZ1 loss-of-function mutation contributes to familial dilated cardiomyopathy. Clin Chem Lab Med 55:1417–1425
Acknowledgments
We are sincerely thankful to the study participants for their dedication to the investigation.
Funding
This study was funded by the grants from the National Natural Science Foundation of China (81470372, 81400244, and 81370400), the Medicine Guided Program of Shanghai, China (17411971000), the Experimental Animal Program of Shanghai, China (17140902400), the Clinical Research Plan of SHDC, Shanghai, China (16CR3005A), the Project Foundation of Health and Family Planning Commission of Shanghai, China (M20170348), and the Fundamental Research Funds for the Central Universities.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that no conflict of interest exists.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study or their legal guardians.
Rights and permissions
About this article
Cite this article
Ma, L., Wang, J., Li, L. et al. ISL1 loss-of-function mutation contributes to congenital heart defects. Heart Vessels 34, 658–668 (2019). https://doi.org/10.1007/s00380-018-1289-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-018-1289-z